AT300820B - Verfahren zur Herstellung von Morpholinderivaten - Google Patents

Verfahren zur Herstellung von Morpholinderivaten

Info

Publication number
AT300820B
AT300820B AT562170A AT562170A AT300820B AT 300820 B AT300820 B AT 300820B AT 562170 A AT562170 A AT 562170A AT 562170 A AT562170 A AT 562170A AT 300820 B AT300820 B AT 300820B
Authority
AT
Austria
Prior art keywords
preparation
morpholine derivatives
morpholine
derivatives
Prior art date
Application number
AT562170A
Other languages
German (de)
English (en)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Application granted granted Critical
Publication of AT300820B publication Critical patent/AT300820B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT562170A 1969-06-20 1970-06-22 Verfahren zur Herstellung von Morpholinderivaten AT300820B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3125569 1969-06-20

Publications (1)

Publication Number Publication Date
AT300820B true AT300820B (de) 1972-08-10

Family

ID=10320364

Family Applications (1)

Application Number Title Priority Date Filing Date
AT562170A AT300820B (de) 1969-06-20 1970-06-22 Verfahren zur Herstellung von Morpholinderivaten

Country Status (5)

Country Link
AT (1) AT300820B (enrdf_load_html_response)
BR (1) BR6915221D0 (enrdf_load_html_response)
CS (1) CS167902B2 (enrdf_load_html_response)
GB (1) GB1260886A (enrdf_load_html_response)
PL (1) PL92088B1 (enrdf_load_html_response)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
ATE287878T1 (de) * 1996-08-23 2005-02-15 Neurosearch As Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
AU9087301A (en) 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof
WO2005105763A1 (en) 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
EA015488B1 (ru) 2006-10-18 2011-08-30 Пфайзер Продактс Инк. Содержащие диариловый эфир соединения мочевины
CN116848096A (zh) 2021-03-18 2023-10-03 苏佩努斯制药公司 经取代的吗啉的衍生物及其用途
US20240336581A1 (en) 2023-03-27 2024-10-10 Supernus Pharmaceuticals, Inc. Derivatives of substituted morpholines and uses thereof

Also Published As

Publication number Publication date
CS167902B2 (enrdf_load_html_response) 1976-05-28
GB1260886A (en) 1972-01-19
PL92088B1 (enrdf_load_html_response) 1977-03-31
BR6915221D0 (pt) 1973-02-13

Similar Documents

Publication Publication Date Title
CH504452A (de) Verfahren zur Herstellung von Morpholinderivaten
AT298508B (de) Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen
CH539642A (de) Verfahren zur Herstellung von Pyrimidinylpyrazolderivaten
CH539068A (de) Verfahren zur Herstellung von Morpholinderivaten
CH509339A (de) Verfahren zur Herstellung von Thiadiazol-Derivaten
CH552593A (de) Verfahren zur herstellung von pyridinthioacetamidderivaten.
CH521934A (de) Verfahren zur Herstellung von Buten-2-ol-4-Derivaten
AT317249B (de) Verfahren zur Herstellung von neuen Dialkyl-xanthin-Derivaten
CH520706A (de) Verfahren zur Herstellung von neuen Bezothiazepinderivaten
AT300820B (de) Verfahren zur Herstellung von Morpholinderivaten
CH552631A (de) Verfahren zur herstellung von n-acylderivaten von phosphoramidothioaten.
CH532061A (de) Verfahren zur Herstellung von Benzodiazepinderivaten
AT296961B (de) Verfahren zur Herstellung von Alkyldihydroxybenzolen
CH531531A (de) Verfahren zur Herstellung von Thiazolidinderivaten
CH540899A (de) Verfahren zur Herstellung von neuen Neriifolin-Derivaten
CH545287A (de) Verfahren zur Herstellung von Butyrophenonderivaten
AT326648B (de) Verfahren zur herstellung von 2-nitro-benzofuranderivaten
CH533629A (de) Verfahren zur Herstellung von Benzodiazepinderivaten
AT296297B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH532069A (de) Verfahren zur Herstellung von 3-Hydroxyisoxazolderivaten
CH543534A (de) Verfahren zur Herstellung von Thiazolidinderivaten
CH518943A (de) Verfahren zur Herstellung von neuen Derivaten des p-Aminoalkyl-benzolsulfonamids
AT305503B (de) Verfahren zur herstellung von neuem 9alpha-fluor-16-fluormethylen-prednisolon-21-oenanthat
AT296298B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH541570A (de) Verfahren zur Herstellung von Isoxazolidinderivaten

Legal Events

Date Code Title Description
ELA Expired due to lapse of time